Home > Insider Trading > Filing (0000947871-10-000554)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486952	Dominique Semon	424 West 33Rd Street, Ste 520 New York NY 10001		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-30	1,699	$0.22	4,303,637	No	4	X	Indirect	See Footnotes
Common Stock	Disposition	2010-04-30	382,542	$0.98	3,921,095	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Disposition	2010-04-30	1,699,140	$0.13	1,699,140	$0.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-10-27	2016-10-31	No	4	X	Indirect

Footnotes

On April 30, 2010 Nexus Gemini L.P. ("Gemini") and Merlin Nexus III, L.P. ("Nexus III") exercised 699,640 and 999,500 Warrants, respectively, and in exchangeacquired 699,640 and 999,500 shares of Common Stock, respectively, at an exercise price of $0.22.
The Reporting Person is the managing member of Nexus Gemini Advisors, LLC and Merlin Biomed Private Equity Advisors, LLC, the investment advisors to Gemini,Merlin Nexus II, L.P. ("Nexus II"), and Nexus III, collectively ("the Funds"). The Funds own direct interests in the reported securities.
The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
On April 30, 2010 Gemini and Nexus III sold 157,516 and 225,026 shares of Common Stock, respectively.